funding

Giacomini to lead largest study of genetic, ethnic differences in effectiveness of leading diabetes drug

Thu Nov 5, 2015

(left to right) The Galega officinalis (aka French lilac) was used as a folk remedy for diabetes symptoms for centuries before analysis of its extracts revealed compounds that lowered blood sugar. Eventually, metformin (molecule and pill) was developed. It is a related molecule that is longer acting and less toxic than the plant extracts. Metformin acts on cells in the liver (center and cross-section right) to reduce glucose production and thus blood sugar.

In people with type 2 diabetes, the body is less able to use the hormone insulin to regulate blood sugar. The disease affects 350 million patients globally—including 29 million in the United States, where it is the leading cause of blindness, kidney failure, and non-accident-related amputations.

Kroetz leads new study of genetics of cancer drugs’ dose-limiting side effects

Mon Jul 27, 2015

Deanna Kroetz, PhD

Taxanes are a class of drugs widely used to treat a variety of cancers, including breast, ovarian, lung, gastric, and head and neck. But dosages are often limited by toxic side effects—most commonly damage to the body’s peripheral nerves, causing numbness, pain, and/or hyper-sensitivity—that can...

Shu awarded funding for infrared fluorescent protein research

Wed Aug 31, 2011

Xiaokun Shu, PhD

Xiaokun Shu, PhD, a faculty member in the UCSF School of Pharmacy, has been awarded $165,000 in first-year funding under the UCSF Program for Breakthrough Biomedical Research (

Reflection: 30 years of top NIH funding for UCSF School of Pharmacy

Wed Dec 22, 2010

Kathy Giacomini, PhD (center), co-chair of the Department of Bioengineering and Therapeutic Sciences, discusses research results in the lab with postdocs Sook Wah Yee (left), and Amber Dahlin (right).

Table of contents

Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support

UCSF technology used to trigger cell death becomes basis of company’s cancer therapy research and development

Thu Jul 8, 2010

James Wells, PhD

A technology developed in the laboratory of James Wells, PhD, chair of the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy, will drive a new approach to cancer treatment that s

California Poison Control System receives funding through June 2010

Fri Dec 11, 2009

The University of California, San Francisco-operated California Poison Control System (CPCS), which had already sent layoff notices to its employees January 15, 2010, has secured funding to rescind the notices and continue to care for Californians, through June 2010, via its free and immediate 24...

Fate of California Poison Control System watched nationwide

Tue Jun 30, 2009

Poison experts nationally are tracking the fate of the California Poison Control System, as California state legislators work to pass an already overdue budget. Operation of the System is dependent upon sufficient state funding, the prospects for which remain bleak.

California Poison Control System layoff notices predicted

Tue Jun 30, 2009

Layoff notices are predicted by mid-July 2009 for California Poison Control System employees unless adequate funding for the System is both included in a new California state budget and a new budget is soon passed by the state legislature.

Impending close of California’s Poison Control System highlighted on public radio

Thu Jun 25, 2009

As California legislators continued to wrangle over the details of a state budget bill, National Public Radio's Kelley Weiss covered the impact of potential cuts on the California Poison Control System.

Governor eliminates California’s Poison Control Service

Wed May 20, 2009

San Francisco, CA (May 20, 2009)—Funding for poison control services has been completely eliminated from the California state budget. Beginning in September of 2009, California will become the only state in the nation without any emergency poison control services for residents or medical...

Topics and Expertise: funding